miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting.
Minini M, Senni A, He X, Proietti S, Liguoro D, Catizone A, Giuliani A, Mancini R, Fuso A, Cucina A, Cao Y, Bizzarri M.
Minini M, et al. Among authors: fuso a.
Cancer Lett. 2021 Nov 1;520:48-56. doi: 10.1016/j.canlet.2021.07.001. Epub 2021 Jul 3.
Cancer Lett. 2021.
PMID: 34229060